Literature DB >> 33223383

Assessing New Drugs in Advanced Cancer: Beyond Randomised Evidence.

D Dodwell1, R Shakir2.   

Abstract

Entities:  

Year:  2020        PMID: 33223383     DOI: 10.1016/j.clon.2020.11.003

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  1 in total

1.  Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer.

Authors:  Hope S Rugo; Adam Brufsky; Xianchen Liu; Benjamin Li; Lynn McRoy; Connie Chen; Rachel M Layman; Massimo Cristofanilli; Mylin A Torres; Giuseppe Curigliano; Richard S Finn; Angela DeMichele
Journal:  NPJ Breast Cancer       Date:  2022-10-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.